Unknown

Dataset Information

The Tie2-agonist Vasculotide rescues mice from influenza virus infection.


ABSTRACT: Seasonal influenza virus infections cause hundreds of thousands of deaths annually while viral mutation raises the threat of a novel pandemic strain. Antiviral drugs exhibit limited efficacy unless administered early and may induce viral resistance. Thus, targeting the host response directly has been proposed as a novel therapeutic strategy with the added potential benefit of not eliciting viral resistance. Severe influenza virus infections are complicated by respiratory failure due to the development of lung microvascular leak and acute lung injury. We hypothesized that enhancing lung endothelial barrier integrity could improve the outcome. Here we demonstrate that the Tie2-agonist tetrameric peptide Vasculotide improves survival in murine models of severe influenza, even if administered

SUBMITTER: Sugiyama MG 

PROVIDER: S-EPMC4457136 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature